Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
19. Oktober 2017 09:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
Cidara Therapeutics to Present at Two Upcoming Conferences
18. September 2017 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
Cidara Provides Corporate Update and Reports Second Quarter 2017 Financial Results
09. August 2017 16:31 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Provides Corporate Update and Reports First Quarter 2017 Financial Results
10. Mai 2017 17:06 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Host Investor Day on April 6, 2017
29. März 2017 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, will host an Investor Day...
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
15. März 2017 17:22 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 15, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial Results
10. November 2016 16:10 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Present at the Stifel 2016 Healthcare Conference
08. November 2016 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced it will...
Cidara Therapeutics and Square 1 Bank Announce $20 Million Credit Facility
02. November 2016 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
13. Oktober 2016 09:20 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the closing...